Dr. Deepak Bhatt and Prof. Philippe Gabriel Steg discuss genotype-guided oral P2Y12-inhibition in patients with ST-segment elevation myocardial infarction undergoing primary PCI (POPular Genetics—0:50); edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients (ENTRUST-AF PCI—3:19); and rapid Assessment of possible ACS in the emergency department with high sensitivity troponin T (RAPID-TnT—4:41).

Clinical Topics: Acute Coronary Syndromes, Anticoagulation Management, Arrhythmias and Clinical EP, Invasive Cardiovascular Angiography and Intervention, Noninvasive Imaging, Atherosclerotic Disease (CAD/PAD), Anticoagulation Management and ACS, Anticoagulation Management and Atrial Fibrillation, Implantable Devices, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Interventions and ACS, Interventions and Coronary Artery Disease, Interventions and Imaging, Angiography, Nuclear Imaging

Keywords: ESC Congress, ESC 19, Acute Coronary Syndrome, Anticoagulants, Arrhythmias, Cardiac, Aspirin, Atrial Fibrillation, Coronary Artery Disease, Embolism, Myocardial Infarction, Percutaneous Coronary Intervention, Stents, Stroke, Thrombosis, Vitamin K, Acute Coronary Syndrome, Adenosine, Anticoagulants, Genotype, Genotyping Techniques, Myocardial Infarction, Percutaneous Coronary Intervention, Standard of Care, Stents, Stroke, Thrombosis, Troponin, Acute Coronary Syndrome, Angiography, Coronary Angiography, Percutaneous Coronary Intervention

< Back to Listings